Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.

Buchacz, K; Brooks, J T; Tong, T; Moorman, A C; Baker, R K; Holmberg, S D; Greenberg, A

Buchacz, K; Brooks, J T; Tong, T; Moorman, A C; Baker, R K; Holmberg, S D; Greenberg, A.

Affiliation

Buchacz K; Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. acu7@cdc.gov

HIV Med ; 7(7): 451-6, 2006 Oct.

Article in En | MEDLINE | ID: mdl-16925731

Subject(s)

Adenine/analogs & derivatives; HIV Infections/drug therapy; Hypophosphatemia; Organophosphonates/adverse effects; Reverse Transcriptase Inhibitors/adverse effects; Adenine/adverse effects; Adult; Antiretroviral Therapy, Highly Active; Female; Humans; Hypophosphatemia/chemically induced; Hypophosphatemia/epidemiology; Incidence; Male; Prospective Studies; Risk Factors; Tenofovir; Treatment Outcome; United States/epidemiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenine / HIV Infections / Hypophosphatemia / Reverse Transcriptase Inhibitors / Organophosphonates Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2006 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links